Actively Recruiting
Transgender In Transition
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2022-11-08
750
Participants Needed
5
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.
CONDITIONS
Official Title
Transgender In Transition
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
- Written informed consent after receiving adequate oral and written information
- Have not started gender-affirming hormonal treatment
You will not qualify if you...
- Pregnancy or breast-feeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, Germany, 60590
Not Yet Recruiting
2
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Actively Recruiting
3
Medical Center of the Ludwig-Maximilians-University of Munich
Munich, Germany
Not Yet Recruiting
4
Universitätsspital Basel
Basel, Switzerland, 4031
Not Yet Recruiting
5
UniversitätsSpital Zürich
Zurich, Switzerland, 8091
Not Yet Recruiting
Research Team
J
Johannes Fuß, MD
CONTACT
J
Johanna Schröder, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here